Klaria Pharma Holding AB (KLAR) — Cash Flow-to-Debt Ratio
Klaria Pharma Holding AB (KLAR) has a Cash Flow-to-Debt Ratio of -0.06x as of December 2025, meaning its operating cash flow of Skr-2.74 Million could theoretically repay 0% of its total liabilities (Skr44.65 Million) in one year. See how much free cash does Klaria Pharma Holding AB generate to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Klaria Pharma Holding AB Cash Flow-to-Debt Ratio (2015–2025)
Historical debt coverage capacity for Klaria Pharma Holding AB across 11 annual periods. Also explore Klaria Pharma Holding AB annual equity growth to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Klaria Pharma Holding AB (2015–2025)
Year-by-year debt coverage analysis for Klaria Pharma Holding AB. For market capitalisation and broader financial context, see Klaria Pharma Holding AB market cap and net worth.
| Year | CF-to-Debt Ratio | Operating CF (SEK) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.78x | Skr-35.04 Million | Skr44.65 Million | ▼ -254.8% |
| 2024 | -0.22x | Skr-11.94 Million | Skr53.96 Million | ▲ +22.3% |
| 2023 | -0.28x | Skr-9.06 Million | Skr31.81 Million | ▲ +74.7% |
| 2022 | -1.13x | Skr-49.73 Million | Skr44.19 Million | ▼ -121.9% |
| 2021 | -0.51x | Skr-24.80 Million | Skr48.89 Million | ▲ +67.2% |
| 2020 | -1.55x | Skr-35.30 Million | Skr22.81 Million | ▼ -105.1% |
| 2019 | -0.75x | Skr-14.80 Million | Skr19.62 Million | ▲ +4.5% |
| 2018 | -0.79x | Skr-9.13 Million | Skr11.55 Million | ▲ +84.6% |
| 2017 | -5.13x | Skr-12.06 Million | Skr2.35 Million | ▲ +28.9% |
| 2016 | -7.22x | Skr-14.39 Million | Skr1.99 Million | ▼ -273.7% |
| 2015 | -1.93x | Skr-4.43 Million | Skr2.29 Million | — |